About Us

Vitreon America, Inc. (Vitreon) has been formed with the goal of disseminating, organizing, and making available on a subscription basis, the entirety, portions, and relevant elements of what is known as James A Duke's Phytochemical and Ethnobotanical Databases.

Prior to the 1940s most of pharmaceuticals consisted of plant-based products and this turning point in the worldwide pharmaceutical industry coincides with a willingness – even urgency – to look back upon plants in their natural essence as a basis for medicinal products.

The reasons for the pharmaceutical industry to look towards nature for medicinal answers are numerous:

  • Chemical formulations are expensive and uncertain: Even when side effects do not prevent potential products from getting to the market, time to market is 8 years on average. Once off-patent, the company can be sued for undisclosed or misrepresented side effects for 5 to 12 years until the limits of liability run out -- unless new liabilities are identified and then new clocks start on lawsuits.
  • Engineered products to date have been difficult to make in a cost-efficient manner.
  • Pharmaceutical sales today are 20% proprietary and 80% generic as the pipelines continue to dry up.
  • Botanicals are the best options for the “non-chemical” actives.

Vitreon America Management Team

Jorgen Sandberg

Chief Executive Officer

Mr. Sandberg has an international background within banking and pharmaceuticals. Within banking, Mr. Sandberg has had a focus on business strategy, asset management and financial analysis, including leadership roles in Landkreditt Bank as Bank Manager and Storebrand ASA as an Asset Manager. Within pharmaceuticals, Mr. Sandberg has had various key roles including Scandinavian Innovation Manager for Eli Lilly, and Nycomed Sales Manager of the Year. He is widely recognized for his coaching, mentoring and training successes.

J. Randall Hoggle
(RPh, DPh, MBA)

Chairman of Board

Dr. Hoggle has over 30 years of leadership experience in the pharmaceutical and medical device industries. He has worked in all aspects of the pharmaceutical industry and his commercial experience includes business development, business turnaround, strategic partnership development, product development, registration and commercialization. Dr. Hoggle currently serves as Chairman of HP Holdings, LLC which consists of six companies in a combination of healthcare products, medical care and information system infrastructure expertise, healthcare product systems and infrastructure services and Emergency Preparedness and Response strategic planning and deployment systems, headquartered in Gaithersburg, Maryland and is Chairman of Intelaform, Inc. and Chairman/President of Domaine Healthcare, Inc. headquartered in Rockville, Maryland.